The IGF/IGF-1 receptor signaling pathway as a potential target for cancer therapy
- 28 February 1999
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 2 (1), 3-8
- https://doi.org/10.1054/drup.1998.0061
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith–Wiedemann and Simpson–Golabi–Behmel syndromesGenes & Development, 1997
- The IGF-I receptor in cell growth, transformation and apoptosisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1997
- Beck-Wiedemann syndrome and Wilms' tumourMolecular Human Reproduction, 1997
- Mouse Mutants Lacking the Type 2 IGF Receptor (IGF2R) Are Rescued from Perinatal Lethality inIgf2andIgf1rNull BackgroundsDevelopmental Biology, 1996
- Insulin‐like growth factor I receptor is required for the mitogenic and transforming activities of the platelet‐derived growth factor receptorJournal of Cellular Physiology, 1995
- Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts.Molecular and Cellular Biology, 1994
- The transforming activity of simian virus 40 large tumor antigenBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1994
- Role of insulin-like growth factors in embryonic and postnatal growthCell, 1993
- Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.Proceedings of the National Academy of Sciences, 1989
- Insulin-like Growth FactorsNew England Journal of Medicine, 1983